Categories Cancer

Facts About Prostate Cancer That Spread to Bones

Facts About Prostate Cancer That Spread to Bones When prostate cancer spreads, the bones are typically the first area affected. Bone metastases can weaken your bones and lead to symptoms like bone pain. There’s no cure for metastatic bone cancer, but treatment options may help alleviate symptoms to keep you comfortable. Prostate cancer is one […]

Read More
Categories Cancer

New lung cancer screening guidelines double the number of smokers eligible for annual scans

New lung cancer screening guidelines double the number of smokers eligible for annual scans More Americans now qualify for yearly scans to detect lung cancer, according to guidelines released Tuesday that may help more Black smokers and women get screened. Lung cancer is the nation’s top cancer killer, causing more than 135,000 deaths each year. […]

Read More
Categories Multiple Myeloma

Cyclin-dependent Kinase Inhibitor Market 2021 | Extensive Market Growth | Opportunities | Impact …

Cyclin-dependent Kinase Inhibitor Market 2021 | Extensive Market Growth | Opportunities | Impact … A complete report on Cyclin-dependent Kinase Inhibitor Market was published by The Data Bridge Market Research to understand the comprehensive setup of Cyclin-dependent Kinase Inhibitor Market industries. Cyclin-dependent Kinase Inhibitor market research report provides professional and broad market report primary and […]

Read More
Categories Multiple Myeloma

Is it Time to Dump XTL Biopharmaceuticals Ltd (XTLB) Stock After it Has Gained 3.42% in a Week?

Is it Time to Dump XTL Biopharmaceuticals Ltd (XTLB) Stock After it Has Gained 3.42% in a Week? Overall market sentiment has been down on X T L Biopharmaceuticals Ltd (XTLB) stock lately. XTLB receives a Bearish rating from InvestorsObserver’s Stock Sentiment Indicator. X T L Biopharmaceuticals Ltd has a Bearish sentiment reading. Find out […]

Read More
Categories Multiple Myeloma

Multiple Myeloma CAR T-Cell Therapy Achieves Response in 73% Patients

Multiple Myeloma CAR T-Cell Therapy Achieves Response in 73% Patients Multiple Myeloma CAR T-Cell Therapy Achieves Response in 73% of Patients clinicalomicsprowebdirectory Scroll Up MORE CONTENT We use cookies to give you a better experience on clinicalomics.com. By continuing to use our site, you are agreeing to the use of cookies as set in our […]

Read More